Will Run Strong to Earnings Aug 3
VVBIV continues to amaze. Just when you think the run is over trader propel this stock higher. Following the old adage - "don't fight the trend" we see VBIV continuing to rise into earnings Aug 3 with brief profit taking along the way. Day traders paradise. Longer term...we're talking weeks...expect VBIV to bask in the glow of being the only self described pan coronavirus vaccine which is a pretty powerful concept. And make no mistake, all of these vaccine makers are dealing with conceptual scientific theories on what will work....so right now, VBIV has just as good a shot at fielding a successful vaccine as the rest. Right now in Robinhood land, 220k RHers hold 
INO an early darling in the vaccine race. VBIV only has 60k in following. Given VBIV is comparatively less expensive, I expect to see significant inflows of RH monies into VBIV as it continues it march towards earnings and beyond. Target price prior to earnings a conservative $9.92. If the RH gang catches on could go to $15-18 range and test 5 year highs....worth the time. Remember, "the trend is your friend" and in this red hot biotech space "a rising tide lifts all boats".
INO an early darling in the vaccine race. VBIV only has 60k in following. Given VBIV is comparatively less expensive, I expect to see significant inflows of RH monies into VBIV as it continues it march towards earnings and beyond. Target price prior to earnings a conservative $9.92. If the RH gang catches on could go to $15-18 range and test 5 year highs....worth the time. Remember, "the trend is your friend" and in this red hot biotech space "a rising tide lifts all boats".
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.